Related Experiment Video
Updated: Aug 9, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Substance P, a neuropeptide, inhibits measles virus replication in cell culture
Abstract:
Substance P, a neuropeptide of the tachykinin group, inhibits measles virus replication in cell culture and partially blocks viral fusion activity assayed in the haemolysis system. The ID50 for the inhibition of measles virus single-cycle replication is 0.6 mumol/l, and the effect is fully reversible. The antiviral activity of substance P corresponds to that of previously described synthetic tri-to heptapeptides. Tachykinins and these oligopeptides share a short homology with the N-terminus of paramyxovirus fusion proteins.
Insights
Substance P, a neuropeptide, inhibits measles virus replication and fusion in cell cultures. This antiviral effect is reversible and linked to structural similarities with viral fusion proteins.
Area of Science:
- Virology
- Neuroscience
- Molecular Biology
Background:
- Measles virus (MeV) is a significant human pathogen.
- Viral fusion is a critical step in MeV infection.
- Neuropeptides are being investigated for antiviral properties.
Purpose of the Study:
- To investigate the antiviral activity of Substance P against measles virus.
- To determine the mechanism of Substance P's effect on viral replication and fusion.
Main Methods:
- Cell culture experiments to assess measles virus replication.
- Haemolysis assay to measure viral fusion activity.
- Dose-response analysis to determine inhibitory concentrations.
Main Results:
- Substance P significantly inhibits measles virus replication (ID50 = 0.6 μmol/L).
- Substance P partially blocks measles virus fusion activity.
- The antiviral effect of Substance P is fully reversible.
- Structural homology exists between tachykinins and paramyxovirus fusion proteins.
Conclusions:
- Substance P exhibits antiviral properties against measles virus.
- The mechanism involves inhibition of viral replication and fusion.
- Structural similarities may explain the observed antiviral activity.
Related Concept Videos
Respiratory Syncytial Virus Disease
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

